{{noteTA|G1 = ME}} {{Medical}} 
{{Infobox medical condition
| name = 高血壓
| image = Grade 1 hypertension.jpg
| caption = 自动臂式[[血压计|血压计]]显示[[动脉|动脉]]的高血压（显示的[[收缩压|收缩压]]为158 mmHg，[[舒张压|舒张压]]99 mmHg以及[[心率|心率]]为80次/分）。
| field = [[心臟病學|心臟病學]]
| synonyms = 動脈高血壓
| symptoms = 無<ref name=CDC2015/>
| complications = [[冠狀動脈疾病|冠狀動脈疾病]]、[[中風|中風]]、[[心臟衰竭|心臟衰竭]]、[[周邊動脈阻塞|周邊動脈阻塞]]、[[視力受損|視力受損]]、[[慢性肾脏病|慢性肾脏病]]<ref name="Lack2015" /><ref name="WHO2011" />
| onset = 
| duration = 
| causes = 生活形態或遺傳因素<ref name="Lancet2015">{{Cite journal|title=Hypertension|url=https://pubmed.ncbi.nlm.nih.gov/25832858|last=Poulter|first=Neil R.|last2=Prabhakaran|first2=Dorairaj|date=2015-08-22|journal=Lancet (London, England)|issue=9995|doi=10.1016/S0140-6736(14)61468-9|volume=386|pages=801–812|issn=1474-547X|pmid=25832858|last3=Caulfield|first3=Mark|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220070048/https://pubmed.ncbi.nlm.nih.gov/25832858/|dead-url=no}}</ref><ref name="pmid10645931" />
| risks = 吃太鹹的食物、[[過重|體重過重]]、[[吸烟|吸烟]]、喝酒<ref name="CDC2015" /><ref name="Lancet2015" />
| diagnosis = 休息血壓 > 140/90 mmHg<ref name=Lancet2015/>
| differential = 
| prevention = 
| treatment = 生活形態調整、藥物治療<ref name="NIH2015Tx" />
| medication = 
| prognosis = 
| frequency = 全球約16–37%<ref name="Lancet2015" />
| deaths = 940萬 / 18%（2010年）<ref name="Camp2015" />
}}

<!-- Definition and symptoms -->
'''高血壓'''（{{lang-en|Hypertension}}，high blood pressure）是[[動脈|動脈]][[血壓|血壓]]持續偏高的[[慢性病|慢性疾病]]<ref name="Nai2014">{{Cite book|url=https://books.google.com/books?id=K21_AwAAQBAJ|publisher=Elsevier Health Sciences|date=2014-05-02|isbn=978-0-7020-5249-1|language=en|first=Jeannette|last=Naish|first2=Denise Syndercombe|last2=Court|title=Medical Sciences E-Book|pages=562|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220064742/https://books.google.com/books?id=K21_AwAAQBAJ|dead-url=no}}</ref>。高血壓一般沒有症狀<ref name="CDC2015">{{Cite web |title=High Blood Pressure Fact Sheet |url=https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm |date=2015-02-19 |website=CDC |access-date=2016-03-06 |archive-url=https://web.archive.org/web/20160306125631/http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm |archive-date=2016-03-06 }}</ref>，不過長期高血壓為[[冠狀動脈疾病|冠狀動脈疾病]]、[[中風|中風]]、[[心臟衰竭|心臟衰竭]]、[[心房顫動|心房顫動]]、[[周邊動脈阻塞|周邊動脈阻塞]]、[[視力受損|視力受損]]、[[慢性腎臟病|慢性腎臟病]]及[[失智症|失智症]]等病症的主要危險因子<ref name="Lack2015">{{Cite journal|title=Global burden of cardiovascular disease and stroke: hypertension at the core|url=https://pubmed.ncbi.nlm.nih.gov/25795106|last=Lackland|first=Daniel T.|last2=Weber|first2=Michael A.|date=2015-05|journal=The Canadian Journal of Cardiology|issue=5|doi=10.1016/j.cjca.2015.01.009|volume=31|pages=569–571|issn=1916-7075|pmid=25795106|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220070054/https://pubmed.ncbi.nlm.nih.gov/25795106/|dead-url=no}}</ref><ref name="WHO2011">{{Cite book |url=http://whqlibdoc.who.int/publications/2011/9789241564373_eng.pdf?ua=1 |title=Global atlas on cardiovascular disease prevention and control |first=Shanthi |last2=Puska |first2=Pekka |last3=Norrving |first3=Bo |date=2011 |publisher=World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization |isbn=9789241564373 |edition=1st |location=Geneva |pages=38 |last1=Mendis |name-list-format=vanc |archive-url=https://web.archive.org/web/20140817123106/http://whqlibdoc.who.int/publications/2011/9789241564373_eng.pdf?ua=1 |archive-date=2014-08-17 }}</ref><ref name="Hernandorena2017">{{Cite journal|title=Treatment options and considerations for hypertensive patients to prevent dementia|url=https://pubmed.ncbi.nlm.nih.gov/28532183|last=Hernandorena|first=Intza|last2=Duron|first2=Emmanuelle|date=2017-07|journal=Expert Opinion on Pharmacotherapy|issue=10|doi=10.1080/14656566.2017.1333599|volume=18|pages=989–1000|issn=1744-7666|pmid=28532183|last3=Vidal|first3=Jean-Sébastien|last4=Hanon|first4=Olivier|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220064816/https://pubmed.ncbi.nlm.nih.gov/28532183/|dead-url=no}}</ref><ref name="Lau2017">{{Cite journal|title=Modifiable Risk Factors and Atrial Fibrillation|url=https://pubmed.ncbi.nlm.nih.gov/28784826|last=Lau|first=Dennis H.|last2=Nattel|first2=Stanley|date=2017-08-08|journal=Circulation|issue=6|doi=10.1161/CIRCULATIONAHA.116.023163|volume=136|pages=583–596|issn=1524-4539|pmid=28784826|last3=Kalman|first3=Jonathan M.|last4=Sanders|first4=Prashanthan|access-date=2021-09-26|archive-date=2022-03-05|archive-url=https://web.archive.org/web/20220305111546/https://pubmed.ncbi.nlm.nih.gov/28784826/|dead-url=no}}</ref>。

<!-- Cause and diagnosis -->
高血壓可以分為[[原發性高血壓|原發性高血壓]]和{{le|繼發性高血壓|Secondary hypertension}}<ref name="Lancet2015" />，其中有 90-95% 為原發性高血壓，意即肇因於生活型態或遺傳因素<ref name="Lancet2015" /><ref name="pmid10645931">{{Cite journal|title=Essential hypertension. Part I: definition and etiology|url=https://pubmed.ncbi.nlm.nih.gov/10645931|last=Carretero|first=O. A.|last2=Oparil|first2=S.|date=2000-01-25|journal=Circulation|issue=3|doi=10.1161/01.cir.101.3.329|volume=101|pages=329–335|issn=1524-4539|pmid=10645931|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220070226/https://pubmed.ncbi.nlm.nih.gov/10645931/|dead-url=no}}</ref>。會增加風險的生活型態為[[超重|超重]]、[[吸煙|吸煙]]、飲食含有過量[[食鹽|食鹽]]、[[咖啡|咖啡]]、[[糖|糖]]及喝酒<ref name="CDC2015" /><ref name="Lancet2015" />，剩下的 5-10% 是繼發性高血壓，肇因於其他病症如慢性腎臟病、[[腎動脈狹窄|腎動脈狹窄]]、[[內分泌疾病|內分泌疾病]]或是使用[[避孕藥|避孕藥]]<ref name="Lancet2015" /><ref name = "啟新健康世界-專業健康檢查/醫學健康促進_2021">{{cite web | title = 啟新健康世界-專業健康檢查/醫學健康促進 | url = https://www.ch.com.tw/index.aspx?chapter=ABB010201 | language = zh-tw | accessdate = 2021-12-03 | archive-date = 2022-02-20 | archive-url = https://web.archive.org/web/20220220064842/https://www.ch.com.tw/index.aspx?chapter=ABB010201 | dead-url = no }}</ref>。

<!-- Diagnosis -->
血壓分為收縮壓和舒張壓兩種，即為心臟跳動時{{le|肌肉收縮|systole}}或{{le|舒張|diastole}}時的測量值；收縮壓是血壓的最大值，舒張壓是血壓的最小值<ref name=CDC2015/>。大部分成年人在休息時的收縮壓在 100-130 [[毫米汞柱|毫米汞柱]]（簡稱為 mmHg），舒張壓是 60-80 毫米汞柱<ref name="AHA2017">{{Cite journal|title=2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines|url=https://pubmed.ncbi.nlm.nih.gov/29133356|last=Whelton|first=Paul K.|last2=Carey|first2=Robert M.|date=2018-06|journal=Hypertension (Dallas, Tex.: 1979)|issue=6|doi=10.1161/HYP.0000000000000065|volume=71|pages=e13–e115|issn=1524-4563|pmid=29133356|last3=Aronow|first3=Wilbert S.|last4=Casey|first4=Donald E.|last5=Collins|first5=Karen J.|last6=Dennison Himmelfarb|first6=Cheryl|last7=DePalma|first7=Sondra M.|last8=Gidding|first8=Samuel|last9=Jamerson|first9=Kenneth A.|access-date=2021-09-26|archive-date=2022-02-26|archive-url=https://web.archive.org/web/20220226183933/https://pubmed.ncbi.nlm.nih.gov/29133356/|dead-url=no}}</ref><ref name="EU2013">{{Cite journal|title=2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)|url=https://pubmed.ncbi.nlm.nih.gov/23771844|last=Mancia|first=Giuseppe|last2=Fagard|first2=Robert|date=2013-07|journal=European Heart Journal|issue=28|doi=10.1093/eurheartj/eht151|volume=34|pages=2159–2219|issn=1522-9645|pmid=23771844|last3=Narkiewicz|first3=Krzysztof|last4=Redon|first4=Josep|last5=Zanchetti|first5=Alberto|last6=Böhm|first6=Michael|last7=Christiaens|first7=Thierry|last8=Cifkova|first8=Renata|last9=De Backer|first9=Guy|access-date=2021-09-26|archive-date=2022-03-03|archive-url=https://web.archive.org/web/20220303202536/https://pubmed.ncbi.nlm.nih.gov/23771844/|dead-url=no}}</ref>。若血壓持續超過 130/80 或 140/90 毫米汞柱（收縮壓/舒張壓），有可能是高血壓<ref name="Lancet2015" /><ref name="AHA2017" />。兒童的判斷準則和成人不同<ref name="JNC8">{{Cite journal|title=2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)|url=https://pubmed.ncbi.nlm.nih.gov/24352797|last=James|first=Paul A.|last2=Oparil|first2=Suzanne|date=2014-02-05|journal=JAMA|issue=5|doi=10.1001/jama.2013.284427|volume=311|pages=507–520|issn=1538-3598|pmid=24352797|last3=Carter|first3=Barry L.|last4=Cushman|first4=William C.|last5=Dennison-Himmelfarb|first5=Cheryl|last6=Handler|first6=Joel|last7=Lackland|first7=Daniel T.|last8=LeFevre|first8=Michael L.|last9=MacKenzie|first9=Thomas D.|access-date=2021-09-26|archive-date=2022-03-08|archive-url=https://web.archive.org/web/20220308173851/https://pubmed.ncbi.nlm.nih.gov/24352797/|dead-url=no}}</ref>。量血壓時，採用 24 小時區間的{{le|移動式血壓計測量血壓|ambulatory blood pressure monitoring}}（簡稱為 ABPM）方式會較僅採{{le|診間血壓量測|Office blood pressure monitoring}}（簡稱為 OBPM）來得準確許多<ref name="Lancet2015" /><ref name="Nai2014" />。

<!-- Treatment and epidemiology -->
降低血壓和致命併發症的風險在於改變生活型態與藥物控制<ref name="NIH2015Tx">{{Cite web |title=How Is High Blood Pressure Treated? |url=http://www.nhlbi.nih.gov/health/health-topics/topics/hbp/treatment |date=2015-09-10 |website=National Heart, Lung, and Blood Institute |access-date=2016-03-06 |archive-url=https://web.archive.org/web/20160406073903/http://www.nhlbi.nih.gov/health/health-topics/topics/hbp/treatment |archive-date=2016-04-06 }}</ref>。[[減肥|减少体重]]、[[體能訓練|體能鍛鍊]]、適度{{le|攝取鹽份|Health effects of salt}}、少喝酒及[[均衡飲食|均衡飲食]]等方式都有幫助<ref name="Lancet2015" />，若改變生活型態也無效時，則應使用[[抗高血藥|抗高血藥]]<ref name="NIH2015Tx" />。目前多達3種藥物對九成人類的血壓控制上有效<ref name=Lancet2015/>，而以藥物治療第二期高血壓（收縮壓>160/100 mmHg），有望延長患者的預期壽命<ref>{{Cite journal|title=Pharmacotherapy for hypertension in adults 60 years or older|url=https://doi.wiley.com/10.1002/14651858.CD000028.pub3|last=Musini|first=Vijaya M|last2=Tejani|first2=Aaron M|date=2019-06-05|journal=Cochrane Database of Systematic Reviews|issue=1|doi=10.1002/14651858.CD000028.pub3|editor-last=Cochrane Hypertension Group|volume=2020|language=en|pmc=PMC6550717|pmid=31167038|last3=Bassett|first3=Ken|last4=Puil|first4=Lorri|last5=Wright|first5=James M}}</ref>。但對於正常但偏高血壓及第一期高血壓（即130至160 mmHg）的患者而言，藥效相對不明朗，某些研究認為有效<ref name="AHA2017" /><ref>{{Cite journal|title=Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis|url=https://pubmed.ncbi.nlm.nih.gov/25531552|last=Sundström|first=Johan|last2=Arima|first2=Hisatomi|date=2015-02-03|journal=Annals of Internal Medicine|issue=3|doi=10.7326/M14-0773|volume=162|pages=184–191|issn=1539-3704|pmid=25531552|last3=Jackson|first3=Rod|last4=Turnbull|first4=Fiona|last5=Rahimi|first5=Kazem|last6=Chalmers|first6=John|last7=Woodward|first7=Mark|last8=Neal|first8=Bruce|last9=Blood Pressure Lowering Treatment Trialists' Collaboration|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220064919/https://pubmed.ncbi.nlm.nih.gov/25531552/|dead-url=no}}</ref><ref>{{Cite journal |title=Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis |url=http://www.med-sovet.pro/jour/article/view/1765 |date=January 2016 |journal=Lancet |issue=10017 |doi=10.1016/S0140-6736(15)00805-3 |volume=387 |pages=435–43 |pmid=26559744 |vauthors=Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A |access-date=2019-02-11 |archive-url=https://web.archive.org/web/20190416234426/https://www.med-sovet.pro/jour/article/view/1765 |archive-date=2019-04-16}}</ref>，但亦有其他研究認為沒有幫助<ref name="Diao2012">{{Cite journal|title=Pharmacotherapy for mild hypertension|url=https://pubmed.ncbi.nlm.nih.gov/22895954|last=Diao|first=Diana|last2=Wright|first2=James M.|date=2012-08-15|journal=The Cochrane Database of Systematic Reviews|issue=8|doi=10.1002/14651858.CD006742.pub2|pages=CD006742|issn=1469-493X|pmid=22895954|last3=Cundiff|first3=David K.|last4=Gueyffier|first4=Francois|access-date=2021-09-26|archive-date=2022-03-08|archive-url=https://web.archive.org/web/20220308112523/https://pubmed.ncbi.nlm.nih.gov/22895954/|dead-url=no}}</ref><ref>{{Cite journal|title=Blood pressure targets for hypertension in older adults|url=http://doi.wiley.com/10.1002/14651858.CD011575.pub2|last=Garrison|first=Scott R|last2=Kolber|first2=Michael R|date=2017-08-08|journal=Cochrane Database of Systematic Reviews|issue=8|doi=10.1002/14651858.CD011575.pub2|editor-last=Cochrane Hypertension Group|volume=2017|language=en|pmc=PMC6483478|pmid=28787537|last3=Korownyk|first3=Christina S|last4=McCracken|first4=Rita K|last5=Heran|first5=Balraj S|last6=Allan|first6=G Michael}}</ref><ref>{{Cite journal|title=Pharmacotherapy for hypertension in adults aged 18 to 59 years|url=http://doi.wiley.com/10.1002/14651858.CD008276.pub2|last=Musini|first=Vijaya M|last2=Gueyffier|first2=Francois|date=2017-08-16|journal=Cochrane Database of Systematic Reviews|issue=8|doi=10.1002/14651858.CD008276.pub2|editor-last=Cochrane Hypertension Group|volume=2017|language=en|pmc=PMC6483466|pmid=28813123|last3=Puil|first3=Lorri|last4=Salzwedel|first4=Douglas M|last5=Wright|first5=James M}}</ref>。全球約16至37%的人口患有高血壓<ref name="Lancet2015" />，據信 2010 年全球死亡人數之中，有 18% 與高血壓有關，估計約 940 萬人<ref name="Camp2015">{{Cite journal|title=Using the Global Burden of Disease study to assist development of nation-specific fact sheets to promote prevention and control of hypertension and reduction in dietary salt: a resource from the World Hypertension League|url=https://pubmed.ncbi.nlm.nih.gov/25644474|last=Campbell|first=Norm R. C.|last2=Lackland|first2=Daniel T.|date=2015-03|journal=Journal of Clinical Hypertension (Greenwich, Conn.)|issue=3|doi=10.1111/jch.12479|volume=17|pages=165–167|issn=1751-7176|pmid=25644474|last3=Lisheng|first3=Liu|last4=Niebylski|first4=Mark L.|last5=Nilsson|first5=Peter M.|last6=Zhang|first6=Xin-Hua|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220071754/https://pubmed.ncbi.nlm.nih.gov/25644474/|dead-url=no}}</ref>。

<!--'''高血压'''（{{lang-en|Hypertension (HTN)}}或{{lang|en|high blood pressure}}），全稱'''动脉高血压'''（{{lang|en|Arterial hypertension}}），是一种[[动脉|动脉]][[血压|血压]]升高的[[慢性病|慢性病]]。血压的升高使[[心脏|心脏]]推动[[血液|血液]]在[[血管|血管]]内循环时的负担增大。血压有两种，收缩压和舒张压，分别为心脏跳动时肌肉收缩（systole）或舒张（diastole）时的测量值。正常静息血压范围为收缩压90–139mmHg（最高读数）和舒张压60–89mmHg（最低读数）。血压持续等于或高于140/90毫米汞柱mmHg时则为高血压。

高血压分为{{le|原发性高血压|Essential hypertension}}或{{le|继发性高血压|Secondary hypertension}}。约90–95%的病例为"原发性高血压"，即没有明显病因的高血压。<ref name="pmid10645931">{{Cite journal|title=Essential hypertension. Part I: definition and etiology|url=https://pubmed.ncbi.nlm.nih.gov/10645931|last=Carretero|first=O. A.|last2=Oparil|first2=S.|date=2000-01-25|journal=Circulation|issue=3|doi=10.1161/01.cir.101.3.329|volume=101|pages=329–335|issn=1524-4539|pmid=10645931}}</ref>其余5–10%的病例由影响肾脏、血管、心脏或内分泌系统的其它病症引发（继发性高血压）。

高血压是[[中风|中风]]、[[心肌梗塞|心肌梗塞]]（心梗）、[[心衰竭|心衰竭]]、[[动脉瘤|动脉瘤]]（如[[主动脉瘤|主动脉瘤]]）及[[外周动脉疾病|外周动脉疾病]]等重症的主要{{le|危险因素|Risk factor}}之一，也是[[慢性肾病|慢性肾病]]的起因之一。即使轻度的动脉血压升高也能缩短[[期待寿命|期待寿命]]。改变饮食及生活方式可以改善对血压的控制并减少相关的健康风险。但如果生活方式改变没有起效或效用不佳则这些患者常需要使用药物治疗{{Who}}。

高血壓類性疾病名列[[中國十大死因|中國十大死因]]之一。-->
{{TOC limit|3}}

== 分类 ==
{| class="wikitable" style = "float: right; margin-left:15px; text-align:center"
|-
!分类（2017 ACC/AHA/AAPA/...）<ref name="2017ACC">{{Cite journal|title=2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines|url=https://pubmed.ncbi.nlm.nih.gov/29133354|last=Whelton|first=Paul K.|last2=Carey|first2=Robert M.|date=2018-06|journal=Hypertension (Dallas, Tex.: 1979)|issue=6|doi=10.1161/HYP.0000000000000066|volume=71|pages=1269–1324|issn=1524-4563|pmid=29133354|last3=Aronow|first3=Wilbert S.|last4=Casey|first4=Donald E.|last5=Collins|first5=Karen J.|last6=Dennison Himmelfarb|first6=Cheryl|last7=DePalma|first7=Sondra M.|last8=Gidding|first8=Samuel|last9=Jamerson|first9=Kenneth A.|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220070311/https://pubmed.ncbi.nlm.nih.gov/29133354/|dead-url=no}}</ref>
!收缩压（[[mmHg|mmHg]]）!!關係!!舒张压（mmHg）
|-
| 正常|| <120||和|| <80
|-
| 高血壓前期|| 120–129||和|| <80
|-
| 高血压一期|| 130~139||或||80~89
|-
| 高血压二期|| <math>\geq </math>140||或||<math>\geq </math>90
|-
| {{le|单纯收缩性高血压|systolic hypertension|单纯收缩<br/>高血压}}
| ≥140
|
| <90
|}

=== 成人 ===
对18岁及以上人群的高血压的定义为收缩压和／或舒张压值持续高于公认的正常值（目前此值为收缩压139mmHg毫米汞柱、舒张压89mmHg毫米汞柱：请参见分类表（））。如果使用24小时血压监测数值及家庭自测数值时，则应使用较低的阈值（收缩压135mmHg或舒张压85mmHg）。<ref name="NICE127 full">{{Cite book |url=http://www.nice. org. uk/nicemedia/live/13561/56007/56007. pdf |title=Hypertension (NICE CG 127) |last=National Clinical Guidance Centre |date=August 2011 |publisher=[[National_Institute_for_Health_and_Clinical_Excellence|National Institute for Health and Clinical Excellence]] |accessdate=2011-12-22 |page=102 |chapter=7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations |archiveurl=https://web.archive.org/web/20130719203803/http://nice/ |archivedate=2013-07-19 |deadurl=yes}}</ref>最近的国际高血压指南也对高血压范围之下的血压情况进行了分类，以指出在正常血压范围内的较高血压亦存在的风险。JNC7（2003）<ref name="jnc7">{{Cite journal|title=Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure|url=https://pubmed.ncbi.nlm.nih.gov/14656957|last=Chobanian|first=Aram V.|last2=Bakris|first2=George L.|date=2003-12|journal=Hypertension (Dallas, Tex.: 1979)|issue=6|doi=10.1161/01.HYP.0000107251.49515.c2|volume=42|pages=1206–1252|issn=1524-4563|pmid=14656957|last3=Black|first3=Henry R.|last4=Cushman|first4=William C.|last5=Green|first5=Lee A.|last6=Izzo|first6=Joseph L.|last7=Jones|first7=Daniel W.|last8=Materson|first8=Barry J.|last9=Oparil|first9=Suzanne|access-date=2021-09-26|archive-date=2022-03-08|archive-url=https://web.archive.org/web/20220308121809/https://pubmed.ncbi.nlm.nih.gov/14656957/|dead-url=no}}</ref>将收缩压在120–139 mmHg和/或舒张压在80–89 mmHg的范围定义为临界高血压，而ESH-ESC指南（2007）<ref name="ESH-ESC">{{Cite journal|title=2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension|url=https://pubmed.ncbi.nlm.nih.gov/17762635|last=Mancia|first=Giuseppe|last2=De Backer|first2=Guy|date=2007-09|journal=Journal of Hypertension|issue=9|doi=10.1097/HJH.0b013e3282f0580f|volume=25|pages=1751–1762|issn=0263-6352|pmid=17762635|last3=Dominiczak|first3=Anna|last4=Cifkova|first4=Renata|last5=Fagard|first5=Robert|last6=Germano|first6=Giuseppe|last7=Grassi|first7=Guido|last8=Heagerty|first8=Anthony M.|last9=Kjeldsen|first9=Sverre E.|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220065026/https://pubmed.ncbi.nlm.nih.gov/17762635/|dead-url=no}}</ref>及BHS IV（2004）<ref name="BHSIV">{{Cite journal|title=Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV|url=https://pubmed.ncbi.nlm.nih.gov/14973512|last=Williams|first=B.|last2=Poulter|first2=N. R.|date=2004-03|journal=Journal of Human Hypertension|issue=3|doi=10.1038/sj.jhh.1001683|volume=18|pages=139–185|issn=0950-9240|pmid=14973512|last3=Brown|first3=M. J.|last4=Davis|first4=M.|last5=McInnes|first5=G. T.|last6=Potter|first6=J. F.|last7=Sever|first7=P. S.|last8=McG Thom|first8=S.|last9=British Hypertension Society|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220070325/https://pubmed.ncbi.nlm.nih.gov/14973512/|dead-url=no}}</ref>以最佳、正常及正常高值细分收缩压低于140 mmHg及舒张压低于90 mmHg的组别。高血压也有如下分类：JNC7将高血压分为高血压一期、高血压二期和单纯收缩期高血压。单纯收缩期高血压指收缩压升高而舒张压正常，在老年人中常见。<ref name="jnc7" /> ESH-ESC指南（2007）<ref name="ESH-ESC" />和BHS IV（2004），<ref name="BHSIV" />将收缩压超过179mmHg或舒张压超过109mmHg的患者定义为高血压三期。如果[[药物|药]]无法将血压降低到正常水平，则此高血压为耐药性高血压。<ref name="jnc7" />

=== 新生儿及婴儿 ===
[[新生儿|新生儿]]的高血压很罕见，可见于约0.2－3%的新生儿；健康新生儿的常规检查不包括测量血压。<ref name="Dionne">{{Cite journal|title=Hypertension in infancy: diagnosis, management and outcome|url=https://pubmed.ncbi.nlm.nih.gov/21258818|last=Dionne|first=Janis M.|last2=Abitbol|first2=Carolyn L.|date=2012-01|journal=Pediatric Nephrology (Berlin, Germany)|issue=1|doi=10.1007/s00467-010-1755-z|volume=27|pages=17–32|issn=1432-198X|pmid=21258818|last3=Flynn|first3=Joseph T.|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220065046/https://pubmed.ncbi.nlm.nih.gov/21258818/|dead-url=no}}</ref>在高危新生儿中高血压则较为多见。在决定新生儿血压是否正常时应考虑多种因素，如胎龄（Gestational age），受孕龄和[[出生体重|出生体重]]等。<ref name=Dionne />

===儿童及青少年===
高血压在儿童及青少年中十分常见（按年龄、性别及种族不同，分别为2–9%）<ref>{{Cite journal|title=High blood pressure trends in children and adolescents in national surveys, 1963 to 2002|url=https://pubmed.ncbi.nlm.nih.gov/17846287|last=Din-Dzietham|first=Rebecca|last2=Liu|first2=Yong|date=2007-09-25|journal=Circulation|issue=13|doi=10.1161/CIRCULATIONAHA.106.683243|volume=116|pages=1488–1496|issn=1524-4539|pmid=17846287|last3=Bielo|first3=Marie-Vero|last4=Shamsa|first4=Falah|access-date=2021-09-26|archive-date=2022-03-05|archive-url=https://web.archive.org/web/20220305223444/https://pubmed.ncbi.nlm.nih.gov/17846287/|dead-url=no}}</ref>并被认为在长期可带来其它疾病的风险。<ref name="fourth">{{Cite journal|title=The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents|url=https://pubmed.ncbi.nlm.nih.gov/15286277|last=National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents|date=2004-08|journal=Pediatrics|issue=2 Suppl 4th Report|volume=114|pages=555–576|issn=1098-4275|pmid=15286277|access-date=2021-09-26|archive-date=2022-02-20|archive-url=https://web.archive.org/web/20220220070422/https://pubmed.ncbi.nlm.nih.gov/15286277/|dead-url=no}}</ref>目前的建议为三岁以上的儿童在进行常规医疗检查或治疗时应进行血压测量。应该在重复门诊测量确诊高血压后才定位儿童的高血压。<ref name = fourth />儿童的血压随年龄升高，儿童的高血压诊断标准为三次以上不同时间门诊测量的平均结果等于或高于此儿童相应性别、年龄及身高的95百分位血压。儿童高血压前期的定义为平均收缩压或舒张压大于或等于90百分位，但小于95百分位。<ref name="fourth" />

青少年的高血压和高血压前期诊断及分类建议使用成人标准。<ref name="fourth" />

==-{症}-状与体徵==
高血压很少显示[[症状|症状]]，因此通常是通过{{le|筛查 (医学)|Screening_(medicine)|筛查}}或者寻求解决其它健康问题时发现。一些高血压患者有[[头痛|头痛]]（尤其是后脑勺痛及早上头痛），并有[[头晕|头晕]]、[[眩暈_(醫學)|眩晕]]、[[耳鸣|耳鸣]]（耳中嗡嗡声或咝咝声）、视觉改变或[[昏厥|晕倒发作]]。<ref name="Fisher2005">{{Cite book |title=Harrison's Principles of Internal Medicine |last=Fisher ND, Williams GH |publisher=McGraw-Hill |year=2005 |isbn=0-07-139140-1 |editor-last=Kasper DL, Braunwald E, Fauci AS, ''et al.'' |edition=16th |location=New York, NY |pages=1463–81 |chapter=Hypertensive vascular disease}}</ref>

用[[体检|体检]]{{le|眼底镜检查|Ophthalmoscopy}}检查[[眼底|眼底]]时如检测到{{le|高血压性视网膜病变|Hypertensive retinopathy}}，则应怀疑患有高血压。<ref name="Wong2007">{{Cite journal |title=The eye in hypertension |author=Wong T, Mitchell P |date=February 2007 |journal=Lancet |issue=9559 |doi=10.1016/S0140-6736(07)60198-6 |volume=369 |pages=425–35 |pmid=17276782}}</ref>高血压性视网膜病变的严重程度传统上一般分为一期到四期，但程度较轻的分期之间可能很难互相区别。<ref name=Wong2007/>眼底镜检查结果也可以推断患者患高血压的时间长短。<ref name=Fisher2005/>
===原發性高血壓===
高血壓可以發生於任何年齡，但發現大多數是越過四十歲，約百分之八十五至九十屬於自發性高血壓，其引起原因並不清楚，可能與遺傳和環境因素有關。

===继发性高血压===
一些其它的症状及体征可以将诊断指向{{le|继发性高血压|Secondary hypertension}}，即由可确定的病因如[[肾脏疾病|肾脏疾病]]或[[内分泌疾病|内分泌疾病]]等引起的高血压。如胸腹部肥胖、{{le|葡萄糖不耐受|mpaired_glucose_tolerance}}、{{le|满月脸|moon face}}、“水牛背”及紫色{{le|皮纹|Stretch marks}}为[[库欣氏综合症|库欣氏综合症]]的症状。<ref name="ABC">{{Cite book |title=ABC of hypertension |last=O'Brien, Eoin; Beevers, D. G.; Lip, Gregory Y. H. |publisher=BMJ Books |year=2007 |isbn=1-4051-3061-X |location=London}}</ref>[[甲状腺疾病|甲状腺疾病]]及[[肢端肥大症|肢端肥大症]]也可以引起高血压，它们各有其特殊的症状和体征。<ref name="ABC" />腹部{{le|动脉杂音|Bruit}}可能表明[[肾动脉狭窄|肾动脉狭窄]]（肾脏的供血动脉变狭窄）。腿部血压降低或[[股动脉|股动脉脉冲]]的延迟或缺失可能表明{{le|主动脉缩窄|Coarctation of the aorta}}（距离心脏很近的主动脉狭窄）。具有变化很大的头痛、心悸、脸色苍白和出汗的高血压应马上及时怀疑是否患有{{le|嗜铬细胞瘤|pheochromocytoma}}。<ref name="ABC" />

===高血压危象===
极严重的血压升高（收缩压等于或大于180或舒张压等于或大于110，有时称为恶性或急进性高血压）称为「{{le|高血压危象|Hypertensive crisis}}」。血压达到这些数值之上表明并发症的风险很高。血压在此范围内的患者不一定有症状表现，但相较一般人群有较多出现（22%的病例）头痛<ref>{{Cite journal |title=Hypertension crisis |author=Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T, Papademetriou V |date=December 2010 |journal=Blood Press. |issue=6 |doi=10.3109/08037051.2010.488052 |volume=19 |pages=328–36 |pmid=20504242}}</ref>及头晕。<ref name=Fisher2005/>其它高血压危象的表现有心衰引起的视觉下降或呼吸困难，又或肾衰引起的感觉不适。<ref name="ABC" />大部分高血压危象患者已患有血压升高，但其它触发因素可能引起了突然的血压升高。<ref name="Marik2007">{{Cite journal |title=Hypertensive crises: challenges and management |author=Marik PE, Varon J |url=http://chestjournal.chestpubs.org/content/131/6/1949.long |date=June 2007 |journal=Chest |issue=6 |doi=10.1378/chest.06-2490 |volume=131 |pages=1949–62 |pmid=17565029 |access-date=2013-09-16 |archive-url=https://archive.is/20121204174126/http://chestjournal.chestpubs.org/content/131/6/1949.long# |archive-date=2012-12-04 |dead-url=yes}}</ref>

当严重的血压升高引起了一个或多个器官的直接损害时则为「{{le|高血压急症|hypertensive emergency}}」（以前称为「恶性高血压」）。损害可以包括{{le|高血压脑病|Hypertensive encephalopathy}}，即由脑部肿大和功能障碍引起的头痛和{{le|意识状态改变|Altered level of consciousness}}（意识模糊或嗜睡）。视网膜[[视神经乳头水肿|视神经乳头水肿]]、眼底出血和渗出是靶器官损害的另一迹象。[[胸痛|胸痛]]可能表明心脏肌肉损伤（可以进展为[[心肌梗塞|心肌梗塞]]），有时进展为[[主动脉剥离|主动脉剥离]]，即[[主动脉|主动脉]]内壁撕裂）、气促、咳嗽、咳血痰都是[[肺水肿|肺水肿]]的典型迹象。此病症的肺组织肿胀由[[心脏衰竭|左心室衰竭]]引起，即心脏[[左心室|左心室]]不能充分将血液从肺部泵入动脉系统。<ref name=Marik2007/>肾功能的急速退化（急性肾损伤）和微血管{{le|溶血性贫血|Hemolytic anemia}}（血液细胞的破坏）也可能出现。<ref name=Marik2007/>在这些情况，快速降低血压的目的是要停止正在进行的器官损害。<ref name=Marik2007/>相反在高血压急症没有出现靶器官损害迹象时，没有证据表明必须要迅速地降低血压。过度降低血压并不是没有风险的。<ref name="ABC" />在高血压急症时建议使用口服药物在24至48小时内逐渐降低血压。<ref name=Marik2007/>

===妊娠===
罹患[[妊娠高血压|妊娠高血压]]的孕妇约占怀孕孕妇的8–10%。<ref name="ABC" />患有妊娠高血压的女人，大多数在怀孕前就有原发性高血压。妊娠高血压可能是[[先兆子痫|先兆子痫]]的预兆，这是一种发生于妊娠后期和生产后几个礼拜的严重症状。<ref name="ABC" />先兆子痫的诊断可包括血压增高和尿蛋白。<ref name="ABC" />懷孕婦女約有5%機率會發生先兆子痫，而且约造成全球16%[[孕产妇死亡|孕产妇死亡]]。<ref name="ABC" />先兆子痫亦使宝宝的死亡风险提高两倍。<ref name="ABC" />先兆子痫通常没有症状，而且是由例行筛检检查出来。当发生先兆子痫的症状，最常见的就是头痛、视觉障碍（通常是出现闪光）、呕吐、上腹部疼痛和[[水肿|水肿]]（肿胀）。先兆子痫有时会演变为称之为[[子痫|子痫]]的致命病况。子痫是一种{{le|急性高血压|Hypertensive emergency}}，并且有数种严重的并发症。这些并发症包括丧失视力、脑水肿、[[强直阵挛性癫痫|癫痫发作]]或[[惊厥|惊厥]]、[[肾衰竭|肾衰竭]]、[[肺水肿|肺水肿]]和[[弥散性血管内凝血|弥散性血管内凝血]]（一种血液凝固功能障碍）。<ref name="ABC" /><ref name="urlHypertension and Pregnancy: eMedicine Obstetrics and Gynecology">{{Cite web |title=Hypertension and Pregnancy |url=http://emedicine.medscape.com/article/261435-overview |accessdate=2009-06-16 |author=Gibson, Paul |date=2009-07-30 |work=eMedicine Obstetrics and Gynecology |publisher=Medscape |archive-date=2015-11-15 |archive-url=https://web.archive.org/web/20151115110917/http://emedicine.medscape.com/article/261435-overview |dead-url=no }}</ref>

===婴儿与儿童===
{{le|發育遲緩|Failure to thrive}}、[[癫痫发作|癫痫发作]]、焦躁不安、{{le|缺乏活力|Lethargy}}和[[婴儿呼吸窘迫综合症|呼吸困难]]<ref name="urlHypertension: eMedicine Pediatrics: Cardiac Disease and Critical Care Medicine">{{Cite web |title=Hypertension |url=http://emedicine.medscape.com/article/889877-overview |accessdate=2009-06-16 |author=Rodriguez-Cruz, Edwin |date=2010-04-06 |coauthors=Ettinger, Leigh M |work=eMedicine Pediatrics: Cardiac Disease and Critical Care Medicine |publisher=Medscape |archive-date=2013-06-26 |archive-url=https://www.webcitation.org/6Hef8iyxf?url=http://emedicine.medscape.com/article/889877-overview |dead-url=no }}</ref>都与新生儿至三个月大的婴儿高血压有关。在三个月以上婴儿和儿童当中，高血压可引起头痛，不明的焦躁不安，[[疲倦_(医疗定义)|疲倦]]、{{le|發育遲緩|Failure to thrive}}、[[视力模糊|视力模糊]]、[[鼻出血|流鼻血]]和[[贝尔面瘫|面部神经麻痹]]。<ref name=Dionne/><ref name="urlHypertension: eMedicine Pediatrics: Cardiac Disease and Critical Care Medicine" />

==并发症==
[[File:Main_complications_of_persistent_high_blood_pressure.svg|thumb]]
高血压是全世界过早死亡最重要的可预防因素。<ref>{{Cite web |title=Global health risks: mortality and burden of disease attributable to selected major risks. |url=http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf |accessdate=2012-02-10 |year=2009 |work=World Health Organization |archive-date=2012-02-14 |archive-url=https://web.archive.org/web/20120214111235/http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf |dead-url=no }}</ref>高血压增加罹患[[缺血性心脏病|缺血性心脏病]]、<ref name="pmid12493255">{{Cite journal |title=Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies |author=Lewington S, Clarke R, Qizilbash N, Peto R, Collins R |date=December 2002 |journal=Lancet |issue=9349 |doi=10.1016/S0140-6736(02)11911-8 |volume=360 |pages=1903–13 |pmid=12493255}}</ref> [[中风|中风]]、<ref name="ABC" /> [[外周血管病变|外周血管病变]]、<ref name="pmid18375152">{{Cite journal |title=Management of hypertension in peripheral arterial disease: does the choice of drugs matter? |author=Singer DR, Kite A |date=June 2008 |journal=European Journal of Vascular and Endovascular Surgery |issue=6 |doi=10.1016/j.ejvs.2008.01.007 |volume=35 |pages=701–8 |pmid=18375152}}</ref>和其它心脏疾病的风险，包括[[心脏衰竭|心脏衰竭]]、[[主动脉瘤|主动脉瘤]]、廣泛性[[动脉粥样硬化|动脉粥样硬化]]和[[肺栓塞|肺栓塞]]。<ref name="ABC" />高血压同时也是罹患{{le|认知障碍|Cognitive disorder}}、[[痴呆|痴呆]]和[[慢性肾脏病|慢性肾脏病]]的高风险因素。<ref name="ABC" />
其它并发症包括：
*{{le|高血压性视网膜病变|Hypertensive retinopathy}}
*[[高血压肾病|高血压肾病]]<ref name="pmid19330604">{{Cite journal |title=Reactive oxygen species and dopamine receptor function in essential hypertension |author=Zeng C, Villar VA, Yu P, Zhou L, Jose PA |date=April 2009 |journal=Clinical and Experimental Hypertension |issue=2 |doi=10.1080/10641960802621283 |volume=31 |pages=156–78 |pmid=19330604}}</ref>

==病因==
===原发性高血压===
原发性（特发性）高血压是最常见高血压，占所有高血压病例90–95%。<ref name="pmid10645931" />在几乎所有当代社会中，血压會随着年齡而升高，而晚年罹患高压的风险也相当高。<ref>{{Cite journal |title=Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. |last=Vasan |first=RS |date=2002-02-27|journal=JAMA: the journal of the American Medical Association |issue=8 |volume=287 |pages=1003-10 |pmid=11866648 |coauthors=Beiser, A, Seshadri, S, Larson, MG, Kannel, WB, D'Agostino, RB, Levy, D}}</ref>基因和环境因素可导致高血压。人们已发现许多对血压造成微小影响的常见基因，<ref>The International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478: 103–109
doi:10.1038/nature10405</ref>还有一些对血压造成重大影响的罕见基因，<ref>{{Cite journal |title=Molecular mechanisms of human hypertension. |last=Lifton |first=RP |date=2001-02-23|journal=Cell |issue=4 |volume=104 |pages=545-56 |pmid=11239411 |coauthors=Gharavi, AG, Geller, DS}}</ref>但是对基因如何导致高血压，仍缺乏了解。有些环境因素也会影响血压。有助于降低血压的生活方式因素包括减少饮食中的[[食鹽|食鹽]]摄取，<ref>{{Cite journal |title=A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. |last=He |first=FJ |date=2009 Jun |journal=Journal of human hypertension |issue=6 |volume=23 |pages=363-84 |pmid=19110538 |coauthors=MacGregor, GA}}</ref>多吃水果和低脂产品（也就是高血压防治饮食，例如[[得舒飲食|DASH飲食]]）。[[运动|运动]]、<ref name="ReferenceA">Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, Williams B, Ford GA. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens. 2006;24:215-33.</ref>[[减轻体重|减轻体重]]<ref name="HaslamJames">{{Cite journal |title=Obesity |author=Haslam DW, James WP |journal=Lancet |issue=9492 |doi=10.1016/S0140-6736(05)67483-1 |year=2005 |volume=366 |pages=1197–209 |pmid=16198769}}</ref>和减少饮用含酒精饮料亦有助于降低血压。<ref>{{Cite journal |title=Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program |author=Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA ''et al.'' |journal=JAMA |issue=15 |doi=10.1001/jama.288.15.1882 |year=2002 |volume=288 |pages=1882–8 |pmid=12377087}}</ref>其它可能造成高血压的因素，例如压力、<ref name="ReferenceA" />摄取咖啡因，<ref>Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis. Am J Clin Nutr. 2011;94:1113–26.</ref>以及维他命D不足，<ref>{{Cite journal |title=Vitamin D and hypertension: current evidence and future directions |author=Vaidya A, Forman JP |date=November 2010 |journal=Hypertension |issue=5 |doi=10.1161/HYPERTENSIONAHA.109.140160 |volume=56 |pages=774–9 |pmid=20937970}}</ref>则并未显示出与高血压有直接关系。[[肥胖|肥胖]]常见的[[胰岛素抵抗|胰岛素抵抗]]，是[[代谢综合症|X综合症]]（或称[[代谢综合症|代谢综合症]]）的致病因子之一，也被认为可造成高血压恶化。<ref name="pmid12364344">{{Cite journal |title=Obesity hypertension in children: a problem of epidemic proportions |author=Sorof J, Daniels S |url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=12364344 |date=October 2002 |journal=Hypertension |accessdate=2009-06-03 |issue=4 |doi=10.1161/01.HYP.0000032940.33466.12 |volume=40 |pages=441–447 |pmid=12364344 |archive-date=2012-12-05 |archive-url=https://archive.is/20121205010228/http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=12364344 |dead-url=yes }}</ref>近期研究亦指出，幼年时期发生的情况（例如出生体重过轻、母亲怀孕时抽烟、高PM<sub>2.5</sub>暴露<ref>{{Cite journal |title=Maternal Exposure to Ambient Particulate Matter ≤2.5 µm During Pregnancy and the Risk for High Blood Pressure in Childhood |url=http://hyper.ahajournals.org/content/early/2018/05/11/HYPERTENSIONAHA.117.10944 |last=Zhang |first=Mingyu |last2=Mueller |first2=Noel T. |date=2018-01-01 |journal=Hypertension |doi=10.1161/HYPERTENSIONAHA.117.10944 |pages=HYPERTENSIONAHA.117.10944 |language=en |issn=0194-911X |pmid=29760154 |last3=Wang |first3=Hongjian |last4=Hong |first4=Xiumei |last5=Appel |first5=Lawrence J. |last6=Wang |first6=Xiaobin |access-date=2018-05-18 |archive-url=https://web.archive.org/web/20180519004205/http://hyper.ahajournals.org/content/early/2018/05/11/HYPERTENSIONAHA.117.10944 |archive-date=2018-05-19 |dead-url=yes}}</ref>和缺乏[[哺育母乳|哺育母乳]]）是成年原发性高血压的危险因子。<ref name="Lawlor 2005">{{Cite journal |title=Early life determinants of adult blood pressure. |last=Lawlor |first=DA |date=2005 May |journal=Current opinion in nephrology and hypertension |issue=3 |volume=14 |pages=259-64 |pmid=15821420 |coauthors=Smith, GD}}</ref>然而成人高血压的致病机制仍尚不明。<ref name="Lawlor 2005" />

===继发性高血压===
继发性高血压是由明确的病因所致。肾脏疾病是继发性高血压最常见的病因。<ref name="ABC" />而[[库欣综合征|库欣综合征]]、[[甲状腺亢进|甲状腺亢进]]、[[甲状腺功能低下|甲状腺功能低下]]、[[肢端肥大症|肢端肥大症]]、[[康恩氏综合症|康恩氏综合症]]、[[醛固酮增多症|醛固酮增多症]]、[[高胰島素血症|高胰島素血症]]<ref>Dankner, R., Chetrit, A., Shanik, M. H., Raz, I., & Roth, J. (2009). Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes care, 32(8), 1464-1466.</ref>等内分泌疾病，也可导致高血压。<ref name="ABC" /><ref>Dluhy RG, Williams GH. Endocrine hypertension. In: Wilson JD, Foster DW, Kronenberg HM, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia, Pa: WB Saunders; 1998:729-49.</ref>其它病因则包括[[肥胖|肥胖]]、[[睡眠呼吸暂停症|睡眠呼吸暂停症]]、[[怀孕|怀孕]]、{{le|主动脉缩窄|Coarctation of the aorta}}、过度摄取[[甘草|甘草]]和某些处方药、草药疗方和非法药物。<ref name="ABC" /><ref>{{Cite journal |title=Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension |url=https://archive.org/details/sim_american-journal-of-medicine_2012-01_125_1/page/14 |author=Grossman E, Messerli FH |date=January 2012 |journal=Am. J. Med. |issue=1 |doi=10.1016/j.amjmed.2011.05.024 |volume=125 |pages=14–22 |pmid=22195528}}</ref>

==病理生理==
[[File:Arterial_pressure_diagram.png|thumb]]
大部份患有确立特发性（原发性）高血压的人，血流阻力（{{le|外周总阻力|total peripheral resistance}}）都因高血压而增加，而{{le|心排血量|cardiac output}}却维持正常。<ref>{{Cite journal |title=Hemodynamic aspects of essential hypertension in humans |url=https://archive.org/details/sim_physiological-reviews_1984-04_64_2/page/617 |author=Conway J |date=April 1984 |journal=Physiol. Rev. |issue=2 |volume=64 |pages=617–60 |pmid=6369352}}</ref>有证据表明为何有些年轻人患有高血压或“临界高血压”而具有高心排血量，即心率加快，却有正常的外周血管阻力。这种症状被称为运动功能亢进临界性高血压。<ref name="Palatini">{{Cite journal |title=The role of cardiac autonomic function in hypertension and cardiovascular disease |author=Palatini P, Julius S |date=June 2009 |journal=Curr. Hypertens. Rep. |issue=3 |volume=11 |pages=199–205 |pmid=19442329}}</ref>这些人的心脏输出随着年纪的增长而降低，但外周阻力却随之上升，在老年时期发展成确立特发性高血压的典型症状。<ref name = Palatini />这是否是最后演变成高血压的人的典型模式尚无定论。<ref>{{Cite journal |title=Prediction of future hypertension by casual blood pressure or invasive hemodynamics? A 30-year follow-up study |author=Andersson OK, Lingman M, Himmelmann A, Sivertsson R, Widgren BR |journal=Blood Press. |issue=6 |year=2004 |volume=13 |pages=350–4 |pmid=15771219}}</ref>确诊罹患高血压的患者其外周血管阻力增加，主要是由于小动脉和微动脉的缩窄。<ref>{{Cite journal |title=Physiological aspects of primary hypertension |author=Folkow B |date=April 1982 |journal=Physiol. Rev. |issue=2 |volume=62 |pages=347–504 |pmid=6461865}}</ref>微血管数量或密度的降低亦可使外周阻力增高。<ref>{{Cite journal |title=The microcirculation and hypertension |author=Struijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, le Noble FA, van Essen H |date=December 1992 |journal=J Hypertens Suppl |issue=7 |volume=10 |pages=S147–56 |pmid=1291649}}</ref>高血压也与外周血管弹性的减低有关，<ref>{{Cite journal |title=Arterial and venous compliance in sustained essential hypertension |url=https://archive.org/details/sim_hypertension_1987-08_10_2/page/133 |author=Safar ME, London GM |date=August 1987 |journal=Hypertension |issue=2 |volume=10 |pages=133–9 |pmid=3301662}}</ref>外周血管弹性减低会增加回流心脏的血量、增加心脏{{le|前负荷 (心脏病理学)|Preload (cardiology)|前负荷}}，最后导致{{le|心脏功能失常|diastolic dysfunction}}。发生的血管收缩是否为造成严重原发性高血压的原因之一，仍有待确定。<ref>{{Cite journal |title=Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture |author=Schiffrin EL |date=February 1992 |journal=Hypertension |issue=2 Suppl |volume=19 |pages=II1–9 |pmid=1735561}}</ref>

患有高血压的年长者其{{le|脉压|Pulse pressure}}（心脏收缩和心脏舒张血压之间的差值）会越来越大。这种状况可能与心脏收缩压异常高但心脏舒张压却正常或异常低有关。这种状况就称为{{le|单纯收缩期高血压|isolated systolic hypertension}}。<ref>{{Cite journal |title=Clinical practice. Isolated systolic hypertension in the elderly |author=Chobanian AV |date=August 2007 |journal=N. Engl. J. Med. |issue=8 |doi=10.1056/NEJMcp071137 |volume=357 |pages=789–96 |pmid=17715411}}</ref>患高血压或单纯收缩期高血压的年长者会有高脉压，可归因于[[动脉硬化|动脉硬化]]程度增高。这是种常见的老年并发症，而且可能会因高血压而加剧。<ref>{{Cite journal |title=Mechanisms, pathophysiology, and therapy of arterial stiffness |url=https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_2005-05_25_5/page/932 |author=Zieman SJ, Melenovsky V, Kass DA |date=May 2005 |journal=Arterioscler. Thromb. Vasc. Biol. |issue=5 |doi=10.1161/01.ATV.0000160548.78317.29 |volume=25 |pages=932–43 |pmid=15731494}}</ref>

高血压的动脉系统所见的血流阻力现象，有诸多致病机制予以解释。大多数证据指向下列两个病因或其中之一：
* 肾脏的盐和水调节紊乱，特别是肾内[[肾素血管紧张素系统|肾素血管紧张素系统]]异常。<ref>{{Cite journal |title=Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension |url=https://archive.org/details/sim_journal-of-applied-physiology_2010-12_109_6/page/1998 |author=Navar LG |date=December 2010 |journal=J. Appl. Physiol. |issue=6 |doi=10.1152/japplphysiol.00182.2010a |volume=109 |pages=1998–2000; discussion 2015 |pmc=3006411 |pmid=21148349}}</ref>
* [[交感神经系统|交感神经系统]]异常<ref>{{Cite journal |title=Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension |url=https://archive.org/details/sim_journal-of-applied-physiology_2010-12_109_6/page/1996 |author=Esler M, Lambert E, Schlaich M |date=December 2010 |journal=J. Appl. Physiol. |issue=6 |doi=10.1152/japplphysiol.00182.2010 |volume=109 |pages=1996–8; discussion 2016 |pmid=20185633}}</ref>这些致病机制并不会彼此排斥，而是可能两者都在某种程度上造成大多数原发性高血压病例。人们也推测，[[內皮細胞功能受損|內皮細胞功能受損]]（血管内皮功能受损）和血管[[炎症|炎症]]，也可能使高血压里的外周阻力增加和血管损坏加剧。<ref>{{Cite journal |title=Endothelium-dependent contractions and endothelial dysfunction in human hypertension |author=Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S |date=June 2009 |journal=Br. J. Pharmacol. |issue=4 |doi=10.1111/j.1476-5381.2009.00240.x |volume=157 |pages=527–36 |pmc=2707964 |pmid=19630832}}</ref><ref>{{Cite journal |title=Role of the renin-angiotensin system in vascular inflammation |author=Marchesi C, Paradis P, Schiffrin EL |date=July 2008 |journal=Trends Pharmacol. Sci. |issue=7 |doi=10.1016/j.tips.2008.05.003 |volume=29 |pages=367–74 |pmid=18579222}}</ref>

==诊断==
{| class="wikitable" style = "float: right; margin-left:15px; text-align:center"
|-
|+诊断高血压通常要做的检验
!系统
!检验
|-
| [[泌尿系统|肾脏]]
| [[尿液分析|显微镜尿液分析]]、[[蛋白尿|蛋白尿]]、血清[[血尿素氮|BUN]] <small>([[血尿素氮|血尿素氮]])</small>和/或[[肌酐|肌酐]]
|-
| [[内分泌系统|内分泌]]
| 血清[[钠|钠]]、[[钾|钾]]、[[钙|钙]]、[[促甲状腺激素|TSH]] <small>([[促甲状腺激素|促甲状腺激素]])</small>
|-
| [[代谢|代谢]]
| {{le|葡萄糖测试|Glucose test|空腹血糖}}、总胆固醇、[[高密度脂蛋白|HDL]]和[[LDL|LDL]]胆固醇、[[甘油三酯|甘油三酯]]
|-
| 其它
| [[血细胞比容|血细胞比容]]、[[心电图|心电图]]和{{le|胸部X光检查|chest radiograph}}
|-
|colspan=2 |Sources: ''Harrison's principles of internal medicine''<ref name="isbn0-07-147691-1">{{Cite book |title=Harrison's principles of internal medicine |last=Loscalzo, Joseph; Fauci, Anthony S.; Braunwald, Eugene; Dennis L. Kasper; Hauser, Stephen L; Longo, Dan L. |publisher=McGraw-Hill Medical |year=2008 |isbn=0-07-147691-1}}</ref>其它<ref name="pmid19417858">{{Cite journal |title=The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk |author=Padwal RS |date=May 2009 |journal=Canadian Journal of Cardiology |issue=5 |doi=10.1016/S0828-282X(09)70491-X |volume=25 |pages=279–86 |pmc=2707176 |pmid=19417858 |last3=Khan NA |last4=Grover |first4=S |last5=McKay |first5=DW |last6=Wilson |first6=T |last7=Penner |first7=B |last8=Burgess |first8=E |last9=McAlister |first9=FA |author-separator=, |display-authors=3 |author2=Hemmelgarn BR}}</ref><ref name="pmid18548142">{{Cite journal |title=The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk |author=Padwal RJ |date=June 2008 |journal=Canadian Journal of Cardiology |issue=6 |doi=10.1016/S0828-282X(08)70619-6 |volume=24 |pages=455–63 |pmc=2643189 |pmid=18548142 |last3=Khan NA |last4=Grover |first4=S |last5=McAlister |first5=FA |last6=McKay |first6=DW |last7=Wilson |first7=T |last8=Penner |first8=B |last9=Burgess |first9=E |author-separator=, |display-authors=3 |author2=Hemmelgarn BR}}</ref><ref name="pmid17534459">{{Cite journal |title=The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk |author=Padwal RS |date=May 2007 |journal=Canadian Journal of Cardiology |issue=7 |doi=10.1016/S0828-282X(07)70797-3 |volume=23 |pages=529–38 |pmc=2650756 |pmid=17534459 |last3=McAlister FA |last4=McKay |first4=DW |last5=Grover |first5=S |last6=Wilson |first6=T |last7=Penner |first7=B |last8=Burgess |first8=E |last9=Bolli |first9=P |author-separator=, |display-authors=3 |author2=Hemmelgarn BR}}</ref><ref name="pmid16755312">{{Cite journal |title=The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk |author=Hemmelgarn BR |date=May 2006 |journal=Canadian Journal of Cardiology |issue=7 |doi=10.1016/S0828-282X(06)70279-3 |volume=22 |pages=573–81 |pmc=2560864 |pmid=16755312 |last3=Grover S |last4=Myers |first4=MG |last5=McKay |first5=DW |last6=Bolli |first6=P |last7=Abbott |first7=C |last8=Schiffrin |first8=EL |last9=Honos |first9=G |author-separator=, |display-authors=3 |author2=McAlister FA}}</ref><ref name="pmid16003448">{{Cite journal |title=The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk |author=Hemmelgarn BR |date=June 2005 |journal=Canadian Journal of Cardiology |issue=8 |volume=21 |pages=645–56 |pmid=16003448 |last3=Myers MG |last4=McKay |first4=DW |last5=Bolli |first5=P |last6=Abbott |first6=C |last7=Schiffrin |first7=EL |last8=Grover |first8=S |last9=Honos |first9=G |author-separator=, |display-authors=3 |author2=McAllister FA}}</ref>
|}

当患者的血压持续过高时，就会诊断为患有高血压。传统的做法是<ref name="NICE127 full" />，需要每隔一个月对患者进行一次血压计测量，并重复三次，才能做出诊断。<ref>{{Cite book |url=http://guidance.nice.org.uk/index.jsp?action=download&o=48384 |title=Essential hypertension (NICE CG18) |last=North of England Hypertension Guideline Development Group |date=2004-08-01 |publisher=[[National_Institute_for_Health_and_Clinical_Excellence|National Institute for Health and Clinical Excellence]] |accessdate=2011-12-22 |page=53 |chapter=Frequency of measurements |archive-date=2012-07-14 |archive-url=https://web.archive.org/web/20120714085714/http://guidance.nice.org.uk/index.jsp?action=download&o=48384 |dead-url=no }}</ref>对高血压患者的初始评估包括一个完整的[[病史|历史]]和[[体检|体检]]。随着24小时{{le|动态血压|Ambulatory Blood Pressure}}监控和家用血压器的出现，为避免对患有白大褂恐惧性高血压的患者做出错误诊断，诊断程序随之发生了变化。英国目前的典范做法是，当临床上量到过一次血压高指标之后，马上要做动态测量随访。用七天的家庭血压监测方法进行随访也是可以的，但效果不是太理想。<ref name="NICE127 full" />

一旦诊断为高血压，医生就会设法根据风险因素和其它存在的症状，找出发病的根本原因。{{le|继发性高血压|Secondary hypertension}}多见于青春期前的儿童，而大多数病例是由[[肾病|肾病]]引起的。原发性高血压多见于青少年，有多种危险因素，包括肥胖症和高血压家族史。<ref name="pmid16719248">{{Cite journal |title=Hypertension in children and adolescents |author=Luma GB, Spiotta RT |journal=Am Fam Physician |issue=9 |year=2006 |volume=73 |pages=1558–68 |pmid=16719248 |month=may}}</ref>也可以通过实验室化验，找出导致继发性高血压的可能原因，并确定高血压是否已经对心脏、眼睛和肾脏造成损害。另外还可做其它针对[[糖尿病|糖尿病]]和[[高胆固醇|高胆固醇]]指标的化验，因为这些疾病都是引发[[心脏病|心脏病]]的风险因素，并可能需要治疗。<ref name="pmid10645931" />

测定血清[[肌酐|肌酐]]可以确定是否有肾脏疾病。肾病既可能是导致高血压的原因，也可能是高血压引发的后果。可是单用血清肌酐值有可能会过高估计[[腎功能|肾小球滤过率]]。最近的指导原则提倡使用诸如肾脏病饮食改良（MDRD）公式预测肾小球滤过率（eGFR）。<ref name = JNC7 />预测肾小球滤过率eGFR还可以提供肾功能的其它基线指标，这些指标可以用来监控某些抗高血压药物对肾功能产生的副作用。用尿液样本测试[[蛋白尿|蛋白]]也被用作肾脏疾病的一个次要的标志。还可以做[[心电图|心电图]]（EKG/ECG）测试，以检查是否有迹象表明心脏由于高血压而变得过度疲劳。它也可以显示心肌的增厚（{{le|左心室肥厚|Left ventricular hypertrophy}}）或心脏以前是否出现过较小异常，如无症状心脏病发作。也可以通过做{{le|胸部X光检查|chest radiograph}}或[[超声心动图|超声心动图]]来寻找心脏扩大或损坏的迹象。<ref name="ABC" />

== 最新高血压标准 ==
根据新版指南，最新血压类别共有5个，分别：正常血压 （小于120/80毫米汞柱）；血压升高（收缩压介于120至129毫米汞柱，舒张压小于80毫米汞柱）；高血压1级（收缩压介于130至139毫米汞柱，舒张压介于80至89毫米汞柱）；高血压2级（大于140/90毫米汞柱）；高血压危象（收缩压达到180毫米汞柱 和/或 舒张压达到120毫米汞柱）。<ref>[http://www.sinchew.com.my/node/1701802/%E9%AB%98%E8%A1%80%E5%8E%8B%E9%98%B2%E6%8E%A7%E6%9C%89%E6%96%B0%E6%A0%87%E5%87%86] {{Wayback|url=http://www.sinchew.com.my/node/1701802/%E9%AB%98%E8%A1%80%E5%8E%8B%E9%98%B2%E6%8E%A7%E6%9C%89%E6%96%B0%E6%A0%87%E5%87%86 |date=20171121031835 }} </ref>对此而言，最大的变化在于以前的高血压前期调整为"血压升高"和"高血压1级" 两类别，尤其时高血压1级成为人们的关注重点。

==预防==
患有高血压但没有意识到自己有这一疾病的人为数众多。<ref name="ReferenceB">{{Cite journal |title=Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. |last=Williams |first=B |date=2004 Mar |journal=Journal of human hypertension |issue=3 |volume=18 |pages=139-85 |pmid=14973512 |coauthors=Poulter, NR, Brown, MJ, Davis, M, McInnes, GT, Potter, JF, Sever, PS, McG Thom, S, British Hypertension, Society}}</ref>要减少高血压造成的后果，并尽量减少对抗高血压药物治疗的需要，因此必须有一些针对全民而制定的措施。在开始药物治疗前，建议患者改变生活方式以降低血压。2004年的“英国高血压学会”指南<ref name="ReferenceB" />提出了以下生活方式的改变，这和2002年美国高血压教育计划<ref>{{Cite journal |title=Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program |author=Whelton PK ''et al.'' |journal=JAMA |issue=15 |doi=10.1001/jama.288.15.1882 |year=2002 |volume=288 |pages=1882–1888 |pmid=12377087}}</ref>所列出的预防高血压的主要措施指南是一致的：
*保持正常体重（如身体质量指数20-25公斤/米<sup>2</sup>)。
*将饮食中钠的摄入量减少至<100毫摩尔/天（每天<6克氯化钠或<2.4克的钠）。
*定期从事有氧运动，如快走（在一周的大多数日子里，每天≥30分钟）。
*限制饮酒，男性每天不超过3个单位，妇女每天不超过2个单位。
*每天的饮食中含丰富的水果和蔬菜（例如，每天至少五份）。通过有效的生活方式改变能降低的血压几乎可以和服用一种降压药物所能降低的血压水平媲美。改变两项或更多项生活方式甚至可以达到更佳的效果。<ref name="ReferenceB" />

==治疗==
<!--{{main article|高血壓的治療與管理}}-->
透過生活習慣的改變和{{tsl|en|antihypertensive|抗高血壓藥物}}的介入，可以有效控制高血壓。高血壓的控制目標通常為血壓低於140/90 mmHg 或 160/100 mmHg。一篇2003年的[[系統性文獻回顧|系統性文獻回顧]]指出，血壓每降低5 mmHg 能減少34%的中風機率、21% 罹患[[冠狀動脈疾病|冠狀動脈疾病]]的機率、及降低[[失智症|失智症]]、[[心臟衰竭|心臟衰竭]]和[[心血管疾病|心血管疾病]]的死亡率。<ref>{{Cite journal |title=Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy |author=Law M, Wald N, Morris J |url=http://www.hta.ac.uk/fullmono/mon731.pdf |last2=Wald |journal=Health Technol Assess |issue=31 |doi=10.3310/hta7310 |year=2003 |volume=7 |pages=1–94 |pmid=14604498 |archiveurl=https://web.archive.org/web/20110304150457/http://www.hta.ac.uk/fullmono/mon731.pdf |archivedate=2011-03-04 |deadurl=yes |last3=Morris}}</ref>
===生活方式的改变===
高血压的第一种治疗方法同上面建议的为预防高血壓而进行的生活方式改变是相同的，<ref name="npsppr">{{Cite web |title=NPS Prescribing Practice Review 52: Treating hypertension |url=http://www.nps.org.au/health_professionals/publications/prescribing_practice_review/current/prescribing_practice_review_52 |accessdate=2010-11-05 |date=2010-09-01 |publisher=NPS Medicines Wise |archiveurl=https://web.archive.org/web/20110222125432/http://www.nps.org.au/health_professionals/publications/prescribing_practice_review/current/prescribing_practice_review_52 |archivedate=2011-02-22|deadurl=yes}}</ref>包括饮食模式的变化，<ref>{{Cite journal |title=Long-term effects of weight-reducing diets in hypertensive patients |last=Siebenhofer |first=A |date=2011-09-07 |journal=Cochrane database of systematic reviews (Online) |doi=10.1002/14651858.CD008274.pub2 |volume=9 |pages=CD008274 |pmid=21901719 |coauthors=Jeitler, K, Berghold, A, Waltering, A, Hemkens, LG, Semlitsch, T, Pachler, C, Strametz, R, Horvath, K |editor1-last=Siebenhofer |editor1-first=Andrea}}</ref>即体育锻炼和减轻体重。这些改变都已经被证明具有显著的降低高血压患者血压的功效。<ref>{{Cite journal |title=Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study |author=Blumenthal JA |date=January 2010 |journal=Arch. Intern. Med. |issue=2 |doi=10.1001/archinternmed.2009.470 |volume=170 |pages=126–35 |pmid=20101007 |last3=Hinderliter A |last4=Watkins |first4=L. L. |last5=Craighead |first5=L. |last6=Lin |first6=P.-H. |last7=Caccia |first7=C. |last8=Johnson |first8=J. |last9=Waugh |first9=R. |author-separator=, |display-authors=3 |author2=Babyak MA}}</ref>即使血压高到足以需要立即使用药物的时候，仍然建议患者进行生活方式的改变。一些不同的为减轻心理压力而设制的计划，如[[生物反馈|生物反馈]]、放松术或打坐都被宣传说能降低高血压，然而，科学研究总的来说都还没能证明这些方法的疗效，因为这些研究的质量一般都比较低。<ref name="pmid19822104">{{Cite journal |title=The effects of biofeedback for the treatment of essential hypertension: a systematic review |author=Greenhalgh J, Dickson R, Dundar Y |date=October 2009 |journal=Health Technol Assess |issue=46 |doi=10.3310/hta13460 |volume=13 |pages=1–104 |pmid=19822104 |doi_brokendate=2010-08-21}}</ref><ref name="pmid18350109">{{Cite journal |title=Stress Reduction Programs in Patients with Elevated Blood Pressure: A Systematic Review and Meta-analysis |author=Rainforth MV, Schneider RH, Nidich SI, Gaylord-King C, Salerno JW, Anderson JW |date=December 2007 |journal=Curr. Hypertens. Rep. |issue=6 |doi=10.1007/s11906-007-0094-3 |volume=9 |pages=520–8 |pmc=2268875 |pmid=18350109}}</ref><ref>{{Cite journal |title=Meditation practices for health: state of the research |author=Ospina MB |date=June 2007 |journal=Evid Rep Technol Assess (Full Rep) |issue=155 |pages=1–263 |pmid=17764203 |last3=Karkhaneh M |last4=Tjosvold |first4=L |last5=Vandermeer |first5=B |last6=Liang |first6=Y |last7=Bialy |first7=L |last8=Hooton |first8=N |last9=Buscemi |first9=N |author-separator=, |display-authors=3 |author2=Bond K}}</ref>

进行诸如{{le|低钠盐饮食|Low sodium diet}}之类的饮食变化是非常有益的。长期（4周以上）的低钠盐饮食在[[高加索人种|白种人]]中能有效地降低血压，无论他们是患有高血压还是血压正常的人。<ref name="cochrane2008">{{Cite journal |title=Effect of longer-term modest salt reduction on blood pressure. |url=http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD004937/frame.html |last=He |first=FJ |date=2004 |journal=Cochrane database of systematic reviews (Online) |issue=3 |pages=CD004937 |pmid=15266549 |coauthors=MacGregor, GA |access-date=2013-09-16 |archive-url=https://web.archive.org/web/20110715200059/http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD004937/frame.html |archive-date=2011-07-15 |dead-url=yes}}</ref>此外，{{le|降血压饮食法|DASH diet}}，一种含丰富的坚果、全谷类、鱼类、家禽、水果和蔬菜并备受{{le|国家心脏、肺和血液研究所|National Heart, Lung, and Blood Institute}}推崇的饮食法，也能降低血压。该饮食计划的主要特点之一就是限制含钠盐類的摄入量，尽管此饮食中也包含丰富的[[钾|钾]]、[[镁|镁]]、[[钙|钙]]和[[蛋白质|蛋白质]]。<ref name="dashguide">{{Cite web |title=Your Guide To Lowering Your Blood Pressure With DASH |url=http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf |accessdate=2009-06-08 |format=PDF |archive-date=2012-11-28 |archive-url=https://web.archive.org/web/20121128080838/http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf |dead-url=no }}</ref>

===药物===
几种药物统称为[[抗高血压药|抗高血压药]]，主要用于治疗高血压等疾病。开药方时，医师会考虑到病人的心血管危险（包括心衰与中风危险）及血压读数。<ref name="nps01">{{Cite journal |title=Drug treatment of elevated blood pressure |author=Nelson, Mark |url=http://www.australianprescriber.com/magazine/33/4/108/12 |journal=Australian Prescriber |accessdate=2010-08-11 |issue=33 |pages=108–C112 |archiveurl=https://web.archive.org/web/20100826074015/http://www.australianprescriber.com/magazine/33/4/108/12 |archivedate=2010-08-26|deadurl=yes}}</ref>如果开始执行药物治疗，美国心脏、肺和血液研究院关于高血压的第七次联合会议<ref name="JNC7">{{Cite journal |title=Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure |author=Chobanian AV, Bakris GL, Black R, ''et al.'' |url=http://hyper.ahajournals.org/content/42/6/1206.long |date=December 2003 |journal=Hypertension |issue=6 |doi=10.1161/1.HYP.0000107251.49515.c2 |volume=42 |pages=1206–C52 |pmid=14656957 |access-date=2012-01-01 |archive-url=https://web.archive.org/web/20120520105829/http://hyper.ahajournals.org/content/42/6/1206.long |archive-date=2012-05-20 |dead-url=yes}}</ref>建议医师监督药物治疗的反应并评估任何由此药物引起的不良反应。血压降低5 mmHg可以减少34%的中风危险及21%局部[[缺血性心脏病|缺血性心脏病]]的危险。血压降低也可以降低由[[心血管疾病|心血管疾病]]引起的[[痴呆|痴呆]]、[[心力衰竭|心力衰竭]]和[[死亡率|死亡率]]。<ref>{{Cite journal |title=Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy |author=Law M, Wald N, Morris J |url=http://www.ta.ac.uk/fullmono/mon731.pdf |journal=Health Technol Assess |issue=31 |year=2003 |volume=7 |pages=1–C94 |pmid=14604498}}{{dead link|date=2018年5月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>治疗的目的是要将大多数人的血压降低至140/90 mmHg，并降低患有糖尿病和肾病病人的高血压。有些医务人员建议将血压水平保持在120/80 mmHg以下。<ref name=nps01 /><ref>{{Cite web |title=Prehypertension: Early-stage High Blood Pressure |url=http://www.webmd.com/content/article/73/88927.htm |accessdate=2009-07-03 |date=2009-03-07 |last=Shaw |first=Gina |publisher=WebMD |archive-date=2006-07-22 |archive-url=https://web.archive.org/web/20060722192745/http://www.webmd.com/content/Article/73/88927.htm |dead-url=no }}</ref>如果没有达到血压目标，则需进一步治疗。<ref>{{Cite journal |title=Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals |author=Eni C. Okonofua; Kit N. Simpson; Ammar Jesri; Shakaib U. Rehman; Valerie L. Durkalski; Brent M. Egan |url=http://hyper.ahajournals.org/cgi/content/abstract/47/3/345 |date=2006-01-23 |journal=Hypertension |accessdate=2009-11-22 |issue=2006;47:345 |doi=10.1161/01.HYP.0000200702.76436.4b |volume=47 |pages=345–C51 |pmid=1643045 |archive-url=https://web.archive.org/web/20110629114555/http://hyper.ahajournals.org/cgi/content/abstract/47/3/345 |archive-date=2011-06-29 |dead-url=yes}}</ref>

药物选择的指南及如何制定各种亚组的最佳治疗方法会随着时间更改，且在不同的国家之间也有区别。专家们尚未在最佳药物上取得一致意见。<ref name="Compare10">{{Cite journal |title=Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension. |last=Klarenbach |first=SW |date=2010 May |journal=The Canadian journal of cardiology |issue=5 |volume=26 |pages=e158-63 |pmid=20485695 |coauthors=McAlister, FA, Johansen, H, Tu, K, Hazel, M, Walker, R, Zarnke, KB, Campbell, NR, Canadian Hypertension Education, Program}}</ref>[[科克伦协作组织|科克伦协作组织]]、[[世界卫生组织|世界卫生组织]]和美国指南支持低剂量的[[噻嗪|以噻嗪为基础的利尿剂]]并将其视为首选初期治疗方法。<ref>{{Cite journal |title=First-line drugs for hypertension |author=Wright JM, Musini VM |journal=Cochrane Database Syst Rev |issue=3 |doi=10.1002/14651858.CD001841.pub2 |year=2009 |pages=CD001841 |pmid=19588327 |editor1-last=Wright |editor1-first=James M}}</ref><ref name=Compare10/>英国指南重点强调对于55岁以上的人群或祖籍为非洲或加勒比海的人群采用[[钙通道阻滞剂|钙通道阻滞剂]]（CCB）。指南还建议年轻一点的人群采用[[血管紧张肽I转化酶抑制剂|血管紧张肽I转化酶抑制剂]]（ACEI）作为首选初期治疗方法。<ref name="NICE127-drug" />在日本，治疗初期可使用的6类药物包括：CCB，ACEI/ARB、噻嗪类利尿剂、[[贝塔受体阻滞剂|贝塔受体阻滞剂]]和{{le|阿尔法受体阻滞剂|Alpha blocker}}，这些药物都被视为合理的。在加拿大，除了阿尔法受体阻滞剂外，所有其它药物都可能被当作第一选择。<ref name=Compare10/>

====药物联用====
多数人需要使用多种药物控制高血压。JNC7<ref name = JNC7 /> a和ESH-ESC指南<ref name=ESH-ESC />支持在初期治疗阶段，当心脏收缩压超过目标值20 mmHg或心脏舒张压超过目标值10 mmHg时，使用两种药物。首选的组合为肾素-血管紧张素系统抑制剂和钙通道阻滞剂，或肾素-血管紧张素系统抑制剂和利尿剂。<ref name="sever">{{Cite journal |title=Hypertension management 2011: optimal combination therapy |author=Sever PS, MesserliH |date=October 2011 |journal=Eur. Heart J. |issue=20 |doi=10.1093/eurheartj/ehr177 |volume=32 |pages=2499–C506 |pmid=21697169}}</ref>二线选择方案如下：
* 钙通道阻滞剂配合利尿剂
* 贝塔受体阻滞剂配合利尿剂
* 二氢吡啶通道阻滞剂配合贝塔受体阻滞剂
* 二氢吡啶通道阻滞剂配合维拉帕米或地尔硫卓之一
不推荐联合方案如下：
* 非二氢吡啶钙通道阻滞剂（如维拉帕米或地尔硫卓）配合贝塔受体阻滞剂
*双重肾素-血管紧张素系统阻滞剂（例如血管紧张素转化酶抑制剂+血管紧张素受体拮抗剂）
*肾素-血管紧张素系统阻滞剂和贝塔受体阻滞剂
*贝塔受体阻滞剂和抗肾上腺素药<ref name = sever />
由于存在急性肾衰竭的高风险，务必要避免将血管紧张素转化酶抑制剂或血管紧张素II受体拮抗剂，与一种利尿剂及一种[[非甾体抗炎药|非甾体抗炎药]]（包括选择性环氧合酶和非处方药物，如布洛芬）联合使用。这一形式的药物联用在澳大利亚医药文献中俗称“三重打击（triple whammy）”。<ref name="npsppr" />现已有包含两种固定类型药物联合的片剂。虽然这些药物较为方便，但最好限于已确定需使用各成份的人群使用。<ref>{{Cite book |title=British National Formulary |date=September 2011 |accessdate=2011-12-22 |volume=No. 62 |chapter=2.5.5.1 Angiotensin-converting enzyme inhibitors |chapterurl=http://bnf.org/bnf/bnf/current/2578.htm |archive-date=2021-12-23 |archive-url=https://web.archive.org/web/20211223201747/https://about.medicinescomplete.com/ |dead-url=yes }}</ref>

===老年人===
对于超过60岁和以上的人群，治疗中等和严重高血压会降低死亡率和心血管病副作用。<ref name=Cochrane09/>对80岁以上的人群，之前的治疗方法虽不能大幅将低死亡率但会减低心脏病危险。<ref name="Cochrane09">{{Cite journal |title=Pharmacotherapy for hypertension in the elderly |author=Musini VM, Tejani AM, Bassett K, Wright JM |journal=Cochrane Database Syst Rev |issue=4 |doi=10.1002/14651858.CD000028.pub2 |year=2009 |pages=CD000028 |pmid=19821263 |editor1-last=Musini |editor1-first=Vijaya M}}</ref> [[噻嗪类|噻嗪类]]利尿剂是美国的首选药物，建议的血压目标为低于140/90 mm Hg。<ref>{{Cite journal |title=ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension |author=Aronow WS, Fleg JL, Pepine CJ, ''et al.'' |date=May 2011 |journal=J. Am. Coll. Cardiol. |issue=20 |doi=10.1016/j.jacc.2011.01.008 |volume=57 |pages=2037–C114 |pmid=21524875}}</ref>在修订的英国指南中，[[钙通道阻滞剂|钙通道阻滞剂]]被视为首选治疗方法，目标门诊血压读数低于150/90 mmHg，或动态血压检测或家庭血压检测低于145/85 mmHg。<ref name="NICE127-drug">{{Cite web |title=1.5 Initiating and monitoring antihypertensive drug treatment, including blood pressure targets |url=http://publications.nice.org.uk/hypertension-cg127/guidance#initiating-and-monitoring-antihypertensive-drug-treatment-including-blood-pressure-targets-2 |accessdate=2011-12-23 |author=National Institute Clinical Excellence |date=August 2011 |work=GC127 Hypertension: Clinical management of primary hypertension in adults |archiveurl=https://web.archive.org/web/20120110120002/http://publications.nice.org.uk/hypertension-cg127/guidance#initiating-and-monitoring-antihypertensive-drug-treatment-including-blood-pressure-targets-2 |archivedate=2012-01-10 |deadurl=yes}}</ref>

===顽固性高血压===
顽固性高血压是指即使一次性服用属于不同类型的三种抗高血压剂后，始终保持在目标值之上的高血压。治疗顽固性高血压的指南已经在英国<ref name="NICE-BP">{{Cite web |title=CG34 Hypertension - quick reference guide |url=http://www.nice.org.uk/nicemedia/pdf/cg034quickrefguide.pdf |accessdate=2009-03-04 |date=2006-06-28 |format=PDF |publisher=[[National_Institute_for_Health_and_Clinical_Excellence|National Institute for Health and Clinical Excellence]] |archive-date=2013-03-20 |archive-url=https://web.archive.org/web/20130320000527/http://www.nice.org.uk/nicemedia/pdf/cg034quickrefguide.pdf |dead-url=no }}</ref>和美国出版。<ref name="pmid18391085">{{Cite journal |title=Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research |url=https://archive.org/details/sim_hypertension_2008-06_51_6/page/1403 |author=Calhoun DA |date=June 2008 |journal=Hypertension |issue=6 |doi=10.1161/HYPERTENSIONAHA.108.189141 |volume=51 |pages=1403–C19 |pmid=18391085 |last3=Textor S |last4=Goff |first4=D. C. |last5=Murphy |first5=T. P. |last6=Toto |first6=R. D. |last7=White |first7=A. |last8=Cushman |first8=W. C. |last9=White |first9=W. |author-separator=, |display-authors=3 |author2=Jones D}}</ref>

==患病率==
至2000年，有近十亿人或近于26%的成年人患有高血压。<ref name="pmid15652604">{{Cite journal |title=Global burden of hypertension: analysis of worldwide data |author=Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J |journal=[[The_Lancet|Lancet]] |issue=9455 |doi=10.1016/S0140-6736(05)17741-1 |year=2005 |volume=365 |pages=217–C23 |pmid=15652604}}</ref>该病在发达国家（330,000,000）和发展中国家（639,000,000）均相当普遍。<ref name="pmid15652604" />然而，不同地区的发病率差距颇大，在印度农村低至3.4%（男性）和6.8%（女性），在波兰却高达68.9%（男性）和72.5%（女性）。<ref>{{Cite journal |title=Worldwide prevalence of hypertension: a systematic review |author=Kearney PM, Whelton M, Reynolds K, Whelton PK, He J |date=January 2004 |journal=J. Hypertens. |issue=1 |volume=22 |pages=11–C9 |pmid=15106785}}</ref>
1995年在美国，估计约约四千三百万人患有高血压或服用抗高血压药。这一数字占了美国成年人数的几乎24%。<ref name="pmid7875754">{{Cite journal |title=Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–C1991 |author=Burt VL |url=http://hyper.ajournals.org/cgi/pmidlookup?view=long&pmid=7875754 |date=March 1995 |journal=Hypertension |accessdate=2009-06-05 |issue=3 |volume=25 |pages=30–¨C13 |pmid=7875754 |last3=Roccella EJ |last4=Brown |first4=C |last5=Cutler |first5=JA |last6=Higgins |first6=M |last7=Horan |first7=MJ |last8=Labarthe |first8=D |author-separator=, |display-authors=3 |author2=Whelton P}}{{dead link|date=2018年5月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>美国患有高血压的人群比率一直在增长，并于2004年达到了29%。<ref name="pmid7607734" /><ref name="pmid17608879">{{Cite journal |title=Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004 |url=https://archive.org/details/sim_journal-of-the-american-geriatrics-society_2007-07_55_7/page/1056 |author=Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S |date=July 2007 |journal=Journal of the American Geriatrics Society |issue=7 |doi=10.1111/j.1532-5415.2007.01215.x |volume=55 |pages=1056–C65 |pmid=17608879}}</ref>至2006年，美国高血压人数达到了七千六百万（占总人口的34%），且非籍美国成年人以44%的比率成为全球高血压发病率最高的人群。<ref name =AHA2010 />该病在美洲土著人中很常见而在美国白人和[[墨西哥裔美国人|墨西哥裔美国人]]中不是很常见。此发病率随着年龄的增长而升高，而在[[美国东南部|美国东南部]]较高。跟女性相比，高血压在男性中更常见（尽管更年期趋于降低这种差距），在社会经济状况较差的地区也较为普遍。<ref name="pmid10645931" />

===儿童===
儿童患高血压的比率也在增高。<ref name="pmid19421783">{{Cite journal |title=Hypertension in children and adolescents: epidemiology and natural history |author=Falkner B |date=May 2009 |journal=Pediatr. Nephrol. |issue=7 |doi=10.1007/s00467-009-1200-3 |volume=25 |pages=1219–C24 |pmc=2874036 |pmid=19421783}}</ref>多数儿童高血压，尤其在青春期前，继发于潜在的疾病。除了肥胖外，肾疾病是儿童时期高血压病的最常见原因（60-70%）。青少年通常患原发性高血压，占比约85－95%。<ref name="aafp">{{Cite journal |title=Hypertension in children and adolescents |author=Luma GB, Spiotta RT |url=http://www.aafp.org/afp/20060501/1558.html |date=May 2006 |journal=Am Fam Phsician |issue=9 |volume=73 |pages=1558–C68 |pmid=16719248 |access-date=2013-09-16 |archive-date=2008-07-24 |archive-url=https://web.archive.org/web/20080724131757/http://www.aafp.org/afp/20060501/1558.html |dead-url=no }}</ref>

==历史==
===量測===
[[File:William_Harvey_(_1578-1657)_Venenbild.jpg|静脉图，摘自哈维的著作''Exercitatio anatomica de motu cordis et sanguinis in animalibus''《动物心血运动解剖论》]]
现代人对心血管系统的认知始于英國醫生[[威廉·哈维|威廉·哈维]]（William Harvey，1578–1657）医生的这部医学著作《心血运动》（''De otu ordis''）。哈维在著作中描述了血液的循环。1733年英国牧师{{le|斯蒂芬·海尔斯|Stephen Hales}}（Stephen Hales）第一次公布了血压测量结果。<ref name="pmid1744849" /><ref name="Kotchen2011">{{Cite journal |title=Historical trends and milestones in hypertension research: a model of the process of translational research |author=Kotchen TA |date=October 2011 |journal=Hypertension |issue=4 |doi=10.1161/HYPERTENSIONAHA.111.177766 |volume=58 |pages=522–38 |pmid=21859967}}</ref> 1808年[[托马斯·杨|托马斯·杨]]认为高血压是一种疾病，1836年[[理查德·布莱特|理查德·布莱特]]（Richard Bright）也把高血压描述为一种疾病，等等。<ref name="pmid1744849" /> {{le|弗雷德里克·阿克巴·默罕默德|Frederick Akbar Mahomed}}（Frederick Akbar Mahomed，1849–1884）首次报告了一例没有肾病症状的血压升高。<ref>{{Cite book |title=Manual of hypertension |url=https://archive.org/details/manualofhyperten0000unse |publisher=Blackwell Science |year=1995 |isbn=0-86542-861-1 |editor-last=Swales JD |location=Oxford |pages=xiii}}</ref>  然而，直到1896年{{le|希皮奥内·里瓦罗西|Scipione Riva-Rocci}}（Scipione Riva-Rocci）发明了袖套法[[血压计|血压计]]之后，高血压才成为临床病症。<ref>{{Cite book |title=A century of arterial hypertension 1896–1996 |publisher=Wiley |year=1996 |isbn=0-471-96788-2 |editor-last=Postel-Vinay N |location=Chichester |page=213}}</ref>这项发明使得人们可以在临床上测量血压。1905年{{le|尼古拉·柯罗特科夫|Nikolai Korotkoff}}（Nikolai Korotkoff）改进了血压测量技术，提出了{{le|柯氏音|Korotkoff sounds}}概念，即血压计袖套放气时听诊器所听到的的动脉声音。<ref name=Kotchen2011/>

===治療===
历史上对所谓的“硬脉疾病”的治疗方法主要是通过[[放血|放血]]或者采用[[水蛭|水蛭]]减少血量。<ref name="pmid1744849">{{Cite journal |title=From blood pressure to hypertension: the history of research |author=Esunge PM |date=October 1991 |journal=J R Soc Med |issue=10 |volume=84 |pages=621 |pmc=1295564 |pmid=1744849}}</ref>中国的[[黄帝|黄帝]]、[[凯尔苏斯|凯尔苏斯]]、[[盖伦|盖伦]]、以及[[希波克拉底|希波克拉底]]都主张放血。<ref name="pmid1744849" /> 19世纪和20世纪，在有效的高血压药物治疗方法问世以前，有三种高血压治疗方法，都有很多副作用。这些方法包括严格的钠限制（例如米饭饮食<ref name="pmid1744849" />）、{{le|交感神经切除术|Sympathectomy}}（外科手术切除部分[[交感神经|交感神经]]系统）、以及热原质治疗（注射引起发热的物质，间接降低血压）。<ref name="pmid1744849" /><ref name="Dustan">{{Cite journal |title=Controlling hypertension. A research success story |author=Dustan HP, Roccella EJ, Garrison HH |date=September 1996 |journal=Arch. Intern. Med. |issue=17 |doi=10.1001/archinte.156.17.1926 |volume=156 |pages=1926–35 |pmid=8823146}}</ref>最早治疗高血压的化学药物[[硫氰酸钠|硫氰酸钠]]在1900年投入使用，但副作用很多，没有得到广泛应用。<ref name="pmid1744849" /> [[第二次世界大战|第二次世界大战]]之后又开发出了几种其它药物。最流行且有效的有[[四甲基氯化铵|四甲基氯化铵]]及其衍生产品{{le|六甲铵|Hexamethonium}}、[[肼屈嗪|肼屈嗪]]和[[利血平|利血平]]（来源于药用植物“[[蛇根木|蛇根木]]”）。第一种耐受良好的口服药物的发现使高血压治疗出现重大突破。这种药物是{{le|氯噻嗪|Chlorothiazide}}，它是第一种[[噻嗪化物|噻嗪化物]][[利尿剂|利尿剂]]，来源于抗生素[[磺胺|磺胺]]并于1958年问世。<ref name="pmid1744849" /><ref>{{Cite journal |title=Benzothiadiazine dioxides as novel diuretics |author=Novello FC, Sprague JM |journal=J. Am. Chem. Soc. |issue=8 |doi=10.1021/ja01565a079 |year=1957 |volume=79 |pages=2028}}</ref>它既能防止液体潴留，又增加盐代谢。[[美国退伍军人事务部|退伍军人管理局]]主办的一次[[随机对照试验|随机对照试验]]对比了[[氢氯噻嗪|氢氯噻嗪]]加上利血平再加上[[肼酞嗪|肼酞嗪]]与[[安慰剂|安慰剂]]治疗高血压。试验因未接受治疗的一部分病人出现了大量的[[并发症|并发症]]，因此认为使他们无法接受治疗是不人道的行为，从而提前终止了试验。试验在较低血压的人群中继续进行，结果显示，即使是轻微高血压病人，该治疗也使得心血管病死亡的风险降低了一半。<ref>{{Cite journal |title=The Veterans Administration Cooperative Study on Antihypertensive Agents. Implications for Stroke Prevention |author=Freis ED |url=http://stroke.ahajournals.org/content/5/1/76.long |journal=Stroke |issue=1 |doi=10.1161/01.STR.5.1.76 |year=1974 |volume=5 |pages=76–77 |format=PDF |pmid=4811316 |access-date=2013-09-16 |archive-date=2012-08-17 |archive-url=https://web.archive.org/web/20120817101209/http://stroke.ahajournals.org/content/5/1/76.long |dead-url=no }}</ref> 1975年，发明氯噻嗪的研究小组获得了[[拉斯克奖|拉斯克公共卫生特别奖]]。<ref name=Dustan/>这些研究的成果促进了公共卫生项目，增强了公众对高血压的认知，普及了高血压的测量和治疗。这些举措为1972-1994年间中风和缺血性心脏病发病率下降50%做出了一定的贡献。<ref name=Dustan/>

==社会和文化==
===认知===
[[File:HTNstudyupd.png|thumb]]的四项研究<ref name="pmid7607734">{{Cite journal |title=Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991 |author=Burt VL |url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=7607734 |date=July 1995 |journal=Hypertension |accessdate=2009-06-05 |issue=1 |volume=26 |pages=60–9 |pmid=7607734 |last3=Higgins M |last4=Horan |first4=MJ |last5=Labarthe |first5=D |last6=Whelton |first6=P |last7=Brown |first7=C |last8=Roccella |first8=EJ |author-separator=, |display-authors=3 |author2=Cutler JA |archive-date=2012-12-20 |archive-url=https://archive.is/20121220113643/http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=7607734 |dead-url=yes }}</ref>]]
[[世界卫生组织|世界卫生组织]]已经确认高血压为导致[[心血管病|心血管病]][[死亡率|死亡率]]的主要原因。{{le|世界高血压联盟| The World Hypertension League}}是85个国家高血压社团和联盟的联盟组织，该组织认为，世界范围内50%以上的高血压患者不了解自身的情况。<ref name="pmid17534457">{{Cite journal |title=Impact of World Hypertension Day |author=Chockalingam A |date=May 2007 |journal=Canadian Journal of Cardiology |issue=7 |doi=10.1016/S0828-282X(07)70795-X |volume=23 |pages=517–9 |pmc=2650754 |pmid=17534457}}</ref>为强调这一问题，WHL在2005年发起了一场全球性高血压认知运动，并把每年的5月17日定为{{le|世界高血压日|World_Hypertension_Day}}。过去三年以来，更多的国家社团参与了世界高血压日WHD，并且通过其创新活动向公众传递有关高血压的信息。2007年，47个WHL成员国家参与了这一活动。在WHD所在的那个星期，所有这些国家与地方政府、学术团体、非政府组织、以及私人企业合作，促进高血压认知，通过几个[[大众传播媒体|媒体]]和公众集会进行宣传。他们采用的[[大众传播媒体|大众传播媒体]]包括[[互联网|互联网]]和[[电视|电视]]，信息受众超过2.5亿人。随着发展势头的逐年壮大，WHL有信心把信息基本上传递到所预测的15亿血压升高人群。<ref name="pmid18548140">{{Cite journal |title=World Hypertension Day and global awareness |author=Chockalingam A |date=June 2008 |journal=Canadian Journal of Cardiology |issue=6 |doi=10.1016/S0828-282X(08)70617-2 |volume=24 |pages=441–4 |pmc=2643187 |pmid=18548140}}</ref>

===经济===
在美国，高血压是一种最为常见的慢性医学问题，使得人们需要经常去找初级医疗服务人员。美国心脏学会估计，2010年高血压的直接和间接治疗费用为766亿美元。<ref name="AHA2010">{{Cite journal |title=Heart disease and stroke statistics--2010 update: a report from the American Heart Association |author=Lloyd-Jones D, Adams RJ, Brown TM, ''et al.'' |date=February 2010 |journal=Circulation |issue=7 |doi=10.1161/CIRCULATIONAHA.109.192667 |volume=121 |pages=e46–e215 |pmid=20019324}}</ref>在美国，80%的高血压人群了解他们自己的状况，其中71%服用治疗高血压药物。然而，这些认识到自身状况的人中，仅48%的高血压得到了充分的控制。<ref name = AHA2010 />高血压的诊断，治疗或控制的缺陷不利于高血压的管理。<ref name="pmid19124418">{{Cite journal |title=Hypertension, a health economics perspective |author=Alcocer L, Cueto L |url=http://tak.sagepub.com/cgi/pmidlookup?view=long&pmid=19124418 |date=June 2008 |journal=Therapeutic Advances in Cardiovascular Disease |accessdate=2009-06-20 |issue=3 |doi=10.1177/1753944708090572 |volume=2 |pages=147–55 |pmid=19124418 |archive-date=2012-12-04 |archive-url=https://archive.is/20121204191320/http://tak.sagepub.com/cgi/pmidlookup?view=long&pmid=19124418 |dead-url=yes }}</ref>{{le|医疗服务人员|Health professional}}在控制高血压方面也面临着许多困难，包括病人对服用多种药物来达到控制血压水平的抵触情绪。人们同时也面对坚持服药以及改变生活方式的挑战。尽管如此，实现血压控制目标仍然是可行的。降低血压可以显著减少现代医疗保健方面的费用。<ref name="The Economic Impact of Hypertension">{{Cite journal |title=The Economic Impact of Hypertension |author=William J. Elliott |date=October 2003 |journal=The Journal of Clinical Hypertension |issue=4 |doi=10.1111/j.1524-6175.2003.02463.x |volume=5 |pages=3–13 |pmid=12826765}}</ref><ref name="pmid18345711">{{Cite journal |title=Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers) |author=Coca A |journal=Clinical Drug Investigation |issue=4 |doi=10.2165/00044011-200828040-00002 |year=2008 |volume=28 |pages=211–20 |pmid=18345711}}</ref>

==近年來的研究==
美國一項大規模研究試圖回答一個困擾醫界多年的問題：血壓要多高才算是高血壓？聯邦政府衛生部{{When||time=2018-05-17}}宣布喊停這項研究，但原因並不是研究出了問題，而是結論已經呼之欲出，而且非常重要，必須提前公布：120 mmHg（毫米汞柱）。

SPRINT研究的受試者是9300多位50歲以上、心臟病或腎臟病高風險男女，隨機分為兩組，一組的血壓控制目標是120，另一組是140。研究本來要進行到2017年，但由於結果已經已經呼之欲出，而且對於公眾健康至關重要，因此國家心肺血液研究所（NHLBI）2015年9月11日直接宣布應將標準降至120，相關論文將在近期內發表。<ref>{{Cite web |url=http://www.storm.mg/lifestyle/65506 |title=風傳媒：小小改變搶救無數人命到底多高才算高血壓？美國最新研究給出答案 |accessdate=2015-09-16 |archive-date=2015-09-16 |archive-url=https://web.archive.org/web/20150916235030/http://www.storm.mg/lifestyle/65506 |dead-url=no }}</ref>

==參見==
*[[原發性高血壓|原發性高血壓]]
*[[白大衣高血压|白大衣高血压]]

==参考文獻==
{{Reflist|30em}}

==外部連結==
{{Medical condition classification and resources
|  DiseasesDB     = 6330
|  ICD10           = {{ICD10|I10}}, {{ICD10|I11}}, {{ICD10|I12}}, {{ICD10|I13}}, {{ICD10|I15}}
|  ICD9           = {{ICD9|401}}
|  OMIM           = 145500
|  MedlinePlus    = 000468
|  eMedicineSubj  = med
|  eMedicineTopic = 1106
|  eMedicine_mult = {{eMedicine2|ped|1097}} {{eMedicine2|emerg|267}}
|  MeshID         = D006973
|  Curlie         = Health/Conditions_and_Diseases/Cardiovascular_Disorders/Hypertension/
}}
{{Commons category|Hypertension}} 
{{Wikivoyage|Traveling with high blood pressure|traveling with high blood pressure|information}}
* {{wikiquote-inline}}

{{Authority control}}
[[Category:血管系统疾病|Category:血管系统疾病]]
[[Category:慢性病|Category:慢性病]]
[[Category:高血壓|Category:高血壓]]
[[Category:血壓|Category:血壓]]
[[Category:與肥胖有關的醫學症狀|Category:與肥胖有關的醫學症狀]]
[[Category:老化相關疾病|Category:老化相關疾病]]